Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON34984Withdrawn
Open-label, single-arm trial in cartilage defect of knee and Cartilage damage, sponsored by CellCoTec. Primary endpoints: Device-related adverse events, Process-related adverse events and 3 more. Planned start Aug 2010; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON34984.